2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions

View by Date

Monday, June 3, 2019

4:54pm-5:06pm: Using Ensembles of Machine Learning Classifiers to Maximize the Accuracy and Stability of Molecular Biopsy Interpretation

J. Reeve¹, K. S. Madill-Thomsen², P. F. Halloran and the INTERCOMEX Study Group³

Concurrent Session: Kidney Chronic Antibody Mediated Rejection • Ballroom B

5:06pm-5:18pm: A Clinical Pharmacogenetic Model to Predict the Efficacy of Sirolimus during the Early Administration in Renal Transplant Recipients

Z. Wang, S. Fei, Z. Han, J. Tao, R. Tan, M. Gu

Concurrent Session: Non-Organ Specific: Pharmacogenomics / Pharmacokinetics • Room 210

5:06pm-5:18pm: A Comparison of the BAR, DRM, DRI, sRRI, ET-DRI, D-MELD and SOFT Score to Predict Outcome after Liver Transplantation in the SRTR Database

J. D. de Boer¹, H. Putter², J. J. Blok¹, I. P. Alwayn¹, B. Van Hoek³, A. E. Braat¹

Concurrent Session: Liver: MELD, Allocation and Donor Issues (DCD/ECD) II • Room 302

5:06pm-5:18pm: A Metagene Signature of Lymphocytic Bronchitis Following Lung Transplantation

J. R. Greenland¹, P. Wang², J. J. Brotman², R. Ahuja¹, T. A. Chong², M. Kleinhenz², L. E. Leard², J. A. Golden², S. R. Hays², J. P. Singer², J. Kukreja³, N. Y. Greenland⁴, Z. Lasik⁴, P. Blanc¹

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes III • Room 306

5:06pm-5:18pm: Bronchoalveolar Lavage Biomarkers Predict Lung Transplant Survival

A. Zarinsefat¹, J. Y. Yang², R. Sarwal¹, J. Liberto¹, D. Watson³, S. Verleden⁴, M. Sarwal¹

Concurrent Session: Infections, Antibodies and Biomarkers in Lung Transplantation • Room 206

5:06pm-5:18pm: Cardiovascular Mortality in Transplant Patients; A Population-Based Cohort Study 1988-2013 in Australia and New Zealand

M. Wyld¹, N. De La Mata², P. Masson³, E. O'Lone², A. Webster²

Concurrent Session: Kidney: Cardiovascular and Metabolic II • Ballroom C

5:06pm-5:18pm: Changes in the Fate of KDPI < 35% Kidneys before and after Implementation of the New Kidney Allocation System

K. Eng, E. Grodstein, L. Castellanos Reyes, L. Teperman, C. Sethna, P. Singer

Concurrent Session: Non-Organ Specific: Public Policy & Allocation • Room 311

5:06pm-5:18pm: Discard Patterns in Donors with Non Alcoholic Fatty Liver Disease

M. MacConmara¹, A. Mufti², S. Hanish¹, P. Vagefi¹, S. Tujius², C. Hwang¹

Concurrent Session: Donor Management: All Organs Excluding Kidney • Room 313

5:06pm-5:18pm: Elevated Donor Derived Cell Free DNA (dd-cfDNA) Levels in the Presence of Donor Specific Antibodies (DSA) Are a Strong Predictor of Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients

D. Puliyanda¹, R. D. Swinford², H. Pizzo¹, J. Garrison¹, I. Kim¹, A. M. De Golovine², S. Jordan¹

Concurrent Session: Kidney: Pediatrics II • Room 304

5:06pm-5:18pm: Four-Year Follow Up of Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy

A. Kirk¹, H. Xu¹, A. Ghali², A. Mehta², A. Guasch²

Concurrent Session: Kidney Immunosuppression: Novel Regimens and Drug Minimization II • Veterans Auditorium